Molecular Inflammation Board at the Center for Personalized Medicine

Abroad (travel likely)Recruiting

Conditions

Psoriasis (PsO) · Psoriasis Arthritis · Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) · Spondylarthropathies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospital of Tübingen - Center for Personalized Medicine, Tübingen, Germany
Contact: Study coordinator (Fee Schmitt, Dr.) · zpm-meb@med.uni-tuebingen.de · +4970712981240

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

Psoriasis

Abroad (travel likely)Recruiting

Waltham, United States · Waltham, United States

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Psoriasis · Overweight or Obesity

Abroad (travel likely)RecruitingPHASE4

Phoenix, United States · Fountain Valley, United States

PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

Psoriasis

Abroad (travel likely)Recruiting

Waltham, United States

A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

Psoriasis (PsO) · Enthesitis · Psoriasis Arthritis

Abroad (travel likely)Recruiting

Nanjing, China · Nanjing, China